The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Anesthetic Market Research Report 2025
Synopsis
Intravenous anesthetics are a varied group of compounds that contain such agents as the barbiturates, benzodiazepines, opioids, ketamine, and alpha-2 adrenoceptor agonists Marshall and Longnecker (1996). The intravenous anesthetics are most commonly used for the induction of anesthesia as they act quickly (20 seconds), and induction by this intravenous route is often preferable to induction with an inhalation agent via a face mask.
The global Intravenous Anesthetic market was valued at US$ 4470 million in 2023 and is anticipated to reach US$ 5842.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
North American market for Intravenous Anesthetic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous Anesthetic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravenous Anesthetic include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous Anesthetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Anesthetic.
Report Scope
The Intravenous Anesthetic market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Anesthetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Anesthetic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Segment by Type
Tetrazolium
Ketamine
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravenous anesthetics are a varied group of compounds that contain such agents as the barbiturates, benzodiazepines, opioids, ketamine, and alpha-2 adrenoceptor agonists Marshall and Longnecker (1996). The intravenous anesthetics are most commonly used for the induction of anesthesia as they act quickly (20 seconds), and induction by this intravenous route is often preferable to induction with an inhalation agent via a face mask.
The global Intravenous Anesthetic market was valued at US$ 4470 million in 2023 and is anticipated to reach US$ 5842.6 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
North American market for Intravenous Anesthetic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intravenous Anesthetic is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intravenous Anesthetic include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intravenous Anesthetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Anesthetic.
Report Scope
The Intravenous Anesthetic market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Anesthetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Anesthetic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Segment by Type
Tetrazolium
Ketamine
Other
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravenous Anesthetic Market Overview
1.1 Product Overview and Scope of Intravenous Anesthetic
1.2 Intravenous Anesthetic Segment by Type
1.2.1 Global Intravenous Anesthetic Market Value Comparison by Type (2024-2030)
1.2.2 Tetrazolium
1.2.3 Ketamine
1.2.4 Other
1.3 Intravenous Anesthetic Segment by Application
1.3.1 Global Intravenous Anesthetic Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Intravenous Anesthetic Market Size Estimates and Forecasts
1.4.1 Global Intravenous Anesthetic Revenue 2019-2030
1.4.2 Global Intravenous Anesthetic Sales 2019-2030
1.4.3 Global Intravenous Anesthetic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravenous Anesthetic Market Competition by Manufacturers
2.1 Global Intravenous Anesthetic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravenous Anesthetic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravenous Anesthetic Average Price by Manufacturers (2019-2024)
2.4 Global Intravenous Anesthetic Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Anesthetic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Anesthetic, Product Type & Application
2.7 Intravenous Anesthetic Market Competitive Situation and Trends
2.7.1 Intravenous Anesthetic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Anesthetic Players Market Share by Revenue
2.7.3 Global Intravenous Anesthetic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Anesthetic Retrospective Market Scenario by Region
3.1 Global Intravenous Anesthetic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravenous Anesthetic Global Intravenous Anesthetic Sales by Region: 2019-2030
3.2.1 Global Intravenous Anesthetic Sales by Region: 2019-2024
3.2.2 Global Intravenous Anesthetic Sales by Region: 2025-2030
3.3 Global Intravenous Anesthetic Global Intravenous Anesthetic Revenue by Region: 2019-2030
3.3.1 Global Intravenous Anesthetic Revenue by Region: 2019-2024
3.3.2 Global Intravenous Anesthetic Revenue by Region: 2025-2030
3.4 North America Intravenous Anesthetic Market Facts & Figures by Country
3.4.1 North America Intravenous Anesthetic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravenous Anesthetic Sales by Country (2019-2030)
3.4.3 North America Intravenous Anesthetic Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Anesthetic Market Facts & Figures by Country
3.5.1 Europe Intravenous Anesthetic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravenous Anesthetic Sales by Country (2019-2030)
3.5.3 Europe Intravenous Anesthetic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Anesthetic Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Anesthetic Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravenous Anesthetic Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravenous Anesthetic Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Anesthetic Market Facts & Figures by Country
3.7.1 Latin America Intravenous Anesthetic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravenous Anesthetic Sales by Country (2019-2030)
3.7.3 Latin America Intravenous Anesthetic Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Anesthetic Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Anesthetic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravenous Anesthetic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravenous Anesthetic Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Anesthetic Sales by Type (2019-2030)
4.1.1 Global Intravenous Anesthetic Sales by Type (2019-2024)
4.1.2 Global Intravenous Anesthetic Sales by Type (2025-2030)
4.1.3 Global Intravenous Anesthetic Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Anesthetic Revenue by Type (2019-2030)
4.2.1 Global Intravenous Anesthetic Revenue by Type (2019-2024)
4.2.2 Global Intravenous Anesthetic Revenue by Type (2025-2030)
4.2.3 Global Intravenous Anesthetic Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Anesthetic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intravenous Anesthetic Sales by Application (2019-2030)
5.1.1 Global Intravenous Anesthetic Sales by Application (2019-2024)
5.1.2 Global Intravenous Anesthetic Sales by Application (2025-2030)
5.1.3 Global Intravenous Anesthetic Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Anesthetic Revenue by Application (2019-2030)
5.2.1 Global Intravenous Anesthetic Revenue by Application (2019-2024)
5.2.2 Global Intravenous Anesthetic Revenue by Application (2025-2030)
5.2.3 Global Intravenous Anesthetic Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Anesthetic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Intravenous Anesthetic Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Corporation Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius-Kabi Intravenous Anesthetic Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Intravenous Anesthetic Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Corporation Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Healthcare Intravenous Anesthetic Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Corporation Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 B.Braun Intravenous Anesthetic Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Intravenous Anesthetic Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Hengrui
6.6.1 Hengrui Corporation Information
6.6.2 Hengrui Description and Business Overview
6.6.3 Hengrui Intravenous Anesthetic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hengrui Intravenous Anesthetic Product Portfolio
6.7.5 Hengrui Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Anesthetic Industry Chain Analysis
7.2 Intravenous Anesthetic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Anesthetic Production Mode & Process
7.4 Intravenous Anesthetic Sales and Marketing
7.4.1 Intravenous Anesthetic Sales Channels
7.4.2 Intravenous Anesthetic Distributors
7.5 Intravenous Anesthetic Customers
8 Intravenous Anesthetic Market Dynamics
8.1 Intravenous Anesthetic Industry Trends
8.2 Intravenous Anesthetic Market Drivers
8.3 Intravenous Anesthetic Market Challenges
8.4 Intravenous Anesthetic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
